Hollencrest Capital Management’s Merck MRK Stock Holding History

Hollencrest Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$575K	Buy	4,777 +253	+6%	+$29.2K	0.02%	207
2025 Q4	$476K	Sell	4,524 -340	-7%	-$31.9K	0.02%	219
2025 Q3	$408K	Buy	4,864 +76	+2%	+$6.26K	0.01%	246
2025 Q2	$379K	Sell	4,788 -401	-8%	-$31.9K	0.02%	219
2025 Q1	$466K	Sell	5,189 -630	-11%	-$58.8K	0.02%	199
2024 Q4	$579K	Sell	5,819 -312	-5%	-$32.2K	0.02%	185
2024 Q3	$696K	Buy	6,131 +393	+7%	+$46.7K	0.03%	178
2024 Q2	$710K	Buy	5,738 +1	+0%	+$129	0.03%	168
2024 Q1	$757K	Hold	5,737	–	–	0.03%	162
2023 Q4	$625K	Buy	5,737 +313	+6%	+$32.5K	0.06%	166
2023 Q3	$558K	Buy	5,424 +1	+0%	+$108	0.06%	160
2023 Q2	$626K	Hold	5,423	–	–	0.07%	161
2023 Q1	$577K	Buy	5,423 +1	+0%	+$108	0.06%	164
2022 Q4	$602K	Sell	5,422 -453	-8%	-$46.3K	0.07%	145
2022 Q3	$506K	Hold	5,875	–	–	0.06%	149
2022 Q2	$536K	Buy	5,875 +1	+0%	+$89	0.06%	155
2022 Q1	$482K	Buy	5,874 +1	+0%	+$79	0.04%	195
2021 Q4	$450K	Sell	5,873 -99	-2%	-$7.88K	0.04%	209
2021 Q3	$448K	Hold	5,972	–	–	0.04%	214
2021 Q2	$465K	Sell	5,972 -286	-5%	-$21.3K	0.04%	208
2021 Q1	$461K	Sell	6,258 -743	-11%	-$54.8K	0.04%	207
2020 Q4	$547K	Sell	7,001 -410	-6%	-$31.4K	0.06%	171
2020 Q3	$586K	Buy	7,411 +9	+0.1%	+$705	0.07%	153
2020 Q2	$546K	Sell	7,402 -97	-1%	-$7.3K	0.07%	145
2020 Q1	$550K	Sell	7,499 -3,923	-34%	-$308K	0.08%	140
2019 Q4	$991K	Buy	11,422 +503	+5%	+$41.3K	0.11%	115
2019 Q3	$877K	Buy	10,919 +24	+0.2%	+$1.92K	0.11%	121
2019 Q2	$872K	Buy	10,895 +39	+0.4%	+$2.99K	0.11%	121
2019 Q1	$862K	Sell	10,856 -13	-0.1%	-$972	0.12%	116
2018 Q4	$793K	Buy	10,869 +13	+0.1%	+$918	0.12%	119
2018 Q3	$862K	Sell	10,856 -1,153	-10%	-$73.5K	0.12%	116
2018 Q2	$695K	Sell	12,009 -73	-0.6%	-$4.12K	0.09%	131
2018 Q1	$628K	Sell	12,082 -323	-3%	-$17.4K	0.08%	146
2017 Q4	$666K	Sell	12,405 -4,245	-25%	-$235K	0.09%	140
2017 Q3	$1.02M	Sell	16,650 -43,303	-72%	-$2.63M	0.14%	103
2017 Q2	$3.67M	Buy	59,953 +98	+0.2%	+$5.96K	0.55%	33
2017 Q1	$3.63M	Sell	59,855 -799	-1%	-$48.5K	0.53%	35
2016 Q4	$3.41M	Sell	60,654 -35,733	-37%	-$2.09M	0.51%	41
2016 Q3	$5.74M	Sell	96,387 -1,703	-2%	-$99.6K	0.83%	29
2016 Q2	$5.39M	Buy	98,090 +14,774	+18%	+$786K	0.83%	29
2016 Q1	$4.21M	Buy	83,316 +1,111	+1%	+$54.4K	0.71%	31
2015 Q4	$4.14M	Sell	82,205 -27,327	-25%	-$1.38M	0.73%	34
2015 Q3	$5.16M	Sell	109,532 -13,628	-11%	-$724K	0.89%	32
2015 Q2	$6.69M	Buy	123,160 +52,414	+74%	+$2.94M	0.96%	29
2015 Q1	$3.88M	Buy	70,746 +6,586	+10%	+$373K	0.51%	43
2014 Q4	$3.48M	Sell	64,160 -2,666	-4%	-$149K	0.46%	45
2014 Q3	$3.78M	Buy	66,826 +3,523	+6%	+$198K	0.52%	47
2014 Q2	$3.49M	Sell	63,303 -121,791	-66%	-$6.64M	0.47%	49
2014 Q1	$10M	Buy	185,094 +10,453	+6%	+$541K	1.49%	17
2013 Q4	$8.34M	Buy	+174,641	New	+$7.98M	1.36%	18

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hollencrest Capital Management's MRK Position: Q1 2026 in Review

Hollencrest Capital Management increased its Merck (MRK) stake by 5.6% in Q1 2026, buying an estimated $29.2K and bringing the position to 4,777 shares worth $575K. The position accounts for 0.02% of the portfolio, ranked #207.

Hollencrest Capital Management first reported a position in MRK in Q4 2013 and has held it in 50 quarters since. The position peaked at $10M in Q1 2014. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Hollencrest Capital Management held 4,777 shares of Merck worth $575K as of Q1 2026.
Hollencrest Capital Management bought 253 Merck shares in Q1 2026, an estimated $29.2K.
Merck made up 0.02% of Hollencrest Capital Management's portfolio in Q1 2026, its #207 holding.
Hollencrest Capital Management first reported a position in Merck in Q4 2013 and has held it in 50 quarters since.
Hollencrest Capital Management's Merck position peaked at $10M in Q1 2014.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Hollencrest Capital Management's 13F filing for Q1 2026, filed 7 May 2026.